| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 40,378 | 62,687 | 66,491 | | Cost of Revenue | 34,707 | 57,682 | 53,946 | | | Gross Profit | 5,671 | 5,004 | 12,545 | | | Operating Expenses | | Research Development | 792 | 883 | 983 | | Selling General and Administrative | 9,028 | 12,898 | 10,919 | | Non Recurring |
-
| 2,640 | 701 | | Others |
-
| 200 | 200 | | | | Total Operating Expenses |
-
| 16,622 | 12,803 | | | | Operating Income or Loss | (4,149) | (11,618) | (258) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,791) | 3,427 | 431 | | Earnings Before Interest And Taxes | (8,940) | (8,191) | 173 | | Interest Expense | 209 | 693 | 626 | | Income Before Tax | (9,150) | (8,884) | (453) | | Income Tax Expense | 208 | (334) | 918 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,358) | (8,550) | (1,371) | | | Non-recurring Events | | Discontinued Operations | 1,773 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,584) | (8,550) | (1,371) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,584) | ($8,550) | ($1,371) |
|
0.29% Nasdaq 
Income Statement
